Follow-up of children diagnosed with severe asthma before and during the COVID-19 pandemic.

Publication date: Dec 07, 2023

During the COVID-19 pandemic, health care strategies were explored to ensure the follow-up of children with severe asthma. This was a prospective, observational, and comparative study. Patients in the severe asthma program of a tertiary care children’s hospital were included (n: 74). The extent of control, exacerbations, and hospitalizations during an in-person period (IPP) (March 2019-2020) and an online period (OP) (April 2020-2021) was assessed. A total of 74 patients were enrolled in the IPP compared to 68 (92%) in the OP. During the IPP, 68% (46) of patients had exacerbations versus 46% (31) during the OP (p = 0. 003). During the IPP, 135 total exacerbations were recorded compared to 79 during the OP (p = 0. 001); this accounted for a 41% reduction. During the IPP, 47% (32) of patients had severe exacerbations versus 32% (22) during the OP (p = 0. 048). A total of 91 severe exacerbations were recorded during the IPP compared to 49 during the OP (p = 0. 029); the reduction was 46%. No differences were observed in terms of hospitalization (IPP: 10, OP: 6; p = 0,9). Telemedicine was effective for the follow-up of patients with severe asthma.

Concepts Keywords
Covid asthma
Hospitalizations exacerbation
Pandemic follow-up studies
patient severity


Type Source Name
disease MESH asthma
pathway KEGG Asthma
disease MESH COVID-19 pandemic
disease VO effective

Original Article

(Visited 1 times, 1 visits today)